| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 18.19▲ | 18.07▲ | 18.03▲ | 18.38▼ | 18.62▼ |
| MA10 | 18.13▲ | 18.03▲ | 18.13▲ | 18.09▲ | 21.75▼ |
| MA20 | 18.06▲ | 18.17▲ | 18.41▼ | 18.35▼ | 22.56▼ |
| MA50 | 18.00▲ | 18.52▼ | 18.24▼ | 22.44▼ | 21.90▼ |
| MA100 | 18.13▲ | 18.22▼ | 17.86▲ | 22.65▼ | 16.12▲ |
| MA200 | 18.40▼ | 17.98▲ | 19.54▼ | 22.49▼ | 13.57▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.024▲ | 0.009▲ | -0.058▼ | 0.316▲ | -0.993▼ |
| RSI | 64.687▲ | 49.168▼ | 48.151▼ | 39.458▼ | 39.973▼ |
| STOCH | 89.448▲ | 36.559 | 16.171▼ | 72.895 | 6.850▼ |
| WILL %R | -10.000▲ | -63.470 | -72.789 | -37.716 | -86.813▼ |
| CCI | 112.482▲ | 36.522 | -35.931 | 65.856 | -103.054▼ |
|
Friday, October 30, 2026 04:30 AM
The Marketing Authorization Application (MAA) is supported by positive Phase 3 RINGSIDE results demonstrating statistically significant improvements across the primary and all key secondary endpoints ...
|
|
Friday, October 30, 2026 04:30 AM
Immunome, Inc. (Nasdaq: IMNM) announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) for varegacestat, an investigational oral once-daily gamma ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/26 | 18.25 | 18.98 | 17.82 | 18.21 | 1,270,371 |
| 29/10/26 | 18.88 | 19.30 | 18.11 | 18.29 | 877,799 |
| 28/10/26 | 18.50 | 18.91 | 18.25 | 18.76 | 949,382 |
| 27/10/26 | 17.95 | 19.00 | 17.50 | 18.77 | 1,225,454 |
| 26/10/26 | 17.99 | 18.35 | 17.70 | 17.89 | 910,525 |
| 23/10/26 | 18.13 | 18.25 | 17.65 | 17.99 | 1,378,899 |
| 22/10/26 | 17.78 | 18.30 | 17.585 | 18.26 | 1,761,377 |
| 21/10/26 | 17.99 | 18.44 | 17.85 | 18.00 | 1,545,074 |
| 20/10/26 | 16.74 | 18.27 | 16.55 | 17.92 | 2,016,760 |
| 19/10/26 | 16.60 | 16.92 | 16.44 | 16.77 | 1,139,854 |
|
|
||||
|
|
||||
|
|